Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 1648-1652, August 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aoki, T.
Right arrow Articles by Teller, M. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aoki, T.
Right arrow Articles by Teller, M. N.

Aging and Cancerigenesis

III. Effect of Age on Isoantibody Formation1

Tadao Aoki2 and Morris N. Teller

Division of Experimental Chemotherapy, Sloan-Kettering Institute for Cancer Research, New York, New York

In continuance of the investigation of the possible interrelationship among aging, immunity, and cancerigenesis, isoantibody formation was studied in young and old mice implanted with the homologous EL4 ascites leukemia. The production of isoantibodies was determined weekly in pooled sera using the cytotoxic antibody test and the opsonization technic involving phagocytosis of tumor cells by peritoneal macrophages in vitro following opsonization with isoantibody. Each young adult female Swiss ICR/Ha mouse (3 months old) completely rejected an intradermal implant of 5 x 105 EL4 cells, whereas progressive growth took place in 55% of the 18-month-old female breeders. Relatively high titers of isoantibody were produced in young mice and to a significantly lesser degree in old mice, especially in those succumbing to progressive tumor growth. This difference in isoantibody formation in old and young mice occurred again after a 2nd implantation (i.p.) of 2 x 106 EL4 cells. The importance of these differences is discussed.

1 This work was supported in part by grants from the American Cancer Society, Inc., and by Grants T4CA-5015 and CA 08748 from the National Cancer Institute, National Institutes of Health, USPHS.

2 Visiting Investigator.

Received 1/ 7/66.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.